Sun Pharma Stock Updates Include Price, Market Cap, and Financial Metrics
Sun Pharma's stock performance is tracked in real-time with updates on key metrics such as last traded price, market capitalization, trading volume, price-to-earnings ratio, and earnings per share. Recent data shows prices around 1781 to 1787 INR, market capitalization near 429,000 crore INR, and a price-to-earnings ratio of approximately 35.4. Coverage includes both fundamental and technical analysis to inform investors about market movements and potential impacts on the stock.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 29/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 7 Oct, 04:59 am. Other outlets followed.
- 1